References
- Blair N. P., Jones C. W., Rusin M. M. Pathophysiology of the blood‐retinal barrier in experimental diabetes. Vitreous fluorophotometry using carboxyfluorescein and fluorescein. Arch. Ophthalmol. 1984; 102: 1810–1814
- Grimes P. A., Stone R. A., Laties A. M., Li W. Carboxyfluorescein: a probe of the blood‐ocular barriers with lower membrane permeability than fluorescein. Arch. Ophthalmol. 1982; 100: 635–639
- Tsuboi S., Pedersen J. Permeability of the isolated dog retinal pigment epithelium to Carboxyfluorescein. Invest. Ophthalmol. Vis. Sci. 1986; 27: 1767–1770
- Grimes P. A. Carboxyfluorescein transfer across the blood‐retinal barrier evaluated by quantitative fluorescence microscopy. Comparison with fluorescein. Exper. Eye Res. 1988; 46: 769–784
- Grimes P. A. Fluorescein distribution in retinas of normal and diabetic rats. Exper. Eye Res. 1985; 41: 227–238
- Chen S., Nakamura H., Tamura Z. Studies on the metabolites of fluorescein in rabbit and human urine. Chem. Pharm. Bull. 1980; 28: 1403–1407
- Gibaldi M., Perrier D. Pharmaco‐kinetics. Marcel Dekker, New York 1982
- Grimes P., Stone R. Interaction of fluorescent: organic anion dyes with cells of the blood retinal barrier after intra‐vitreal injection. Invest. Ophthalmol. Vis. Sci. 1985; 26: 337, (Suppl)
- Klein R., Wallow I., Ernest J. Fluorophotometry III. Streptozotocin‐treated rats and rats with pancreatectomy. Arch. Ophthalmol. 1980; 98: 2235–2237
- Smith S., Ashburn F., Pilkerton A., Recant L. Vitreous fluorophotometry in three models of experimental diabetes mellitus. Retina 1982; 2: 121–125
- Kernell A., Arnqvist H. Effect of insulin treatment on the blood‐retinal barrier in rats with Streptozotocin‐induced diabetes. Arch. Ophthalmol. 1983; 101: 968–980
- Carney S., Wong N., Dirks J. Acute effects of Streptozotocin diabetes on rat renal function. J. Lab. Clin. Med. 1979; 93: 950–961
- Jensen P., Sandahl Christiansen J., Steven K., Parving H. Renal function in streptoztocin‐diabetic rats. Diabetologia 1981; 21: 409–414
- Hebden R., Gardiner S., Bennett T., MacDonald I. The influence of Streptozotocin induced diabetes mellitus on fluid and electrolyte handling in rats. Clin. Sci. 1986; 70: 111–117
- Watkins J., Dykstra T. Alterations in biliary excretory function by Streptozotocin induced diabetes. Drug Metab. Disp 1987; 15: 177–183
- Scott L., Ellis T. Small intestinal transit and myoelectric activity in diabetic rats. Gastrointestinal Activity, J. Christensen, 1980; 395–399
- Pascaud X., Ferre J., Genton M., Roger A., Ruckebusch M., Bueno L. Intestinal motility responses to insulin and glucagon in Streptozotocin diabetic rats. Can. J. Physiol. Pharmacol. 1982; 60: 960–967
- Chang E., Bergenstal R., Field M. Diarrhea in Streptozotocin‐treated rats. J. Clin. Invest. 1986; 75: 1666–1670
- Neault T., McLaren J., Brubaker J., Brubaker R. Spectral shift of fluorescein and Carboxyfluorescein in the anterior chamber of the rabbit eye following systemic administration. Curr. Eye Res. 1986; 5: 337–341
- Zeimer R., Blair N., Cunha‐Vaz J. Pharmacokinetic interpretation of vitreous fluorophotometry. Invest. Ophthalmol, Vis. Sci. 1983; 24: 1374–1381
- Maurice D. Theory and methodology of vitreous fluorophotometry. Jpn. J, Ophthalmol. 1985; 29: 119–130